Tofajak Ointment — Tofacitinib 2% (15 g)
Tofajak Ointment (Tofacitinib 2%) is an innovative topical medication belonging to the class of Janus kinase (JAK) inhibitors. The active substance — tofacitinib at a 2% concentration — effectively blocks intracellular signaling pathways of inflammation, which play a key role in the development of many autoimmune skin diseases.
Manufacturer: Cipla, India. Tofajak ointment represents an advanced solution in dermatology, allowing the active ingredient to be delivered directly to the focus of inflammation. This minimizes systemic impact on the body compared to oral forms while maintaining high therapeutic efficacy in treating complex dermatological conditions.
Key Features:
- ✅ Targeted Therapy: Specifically acts on the JAK-STAT pathway, suppressing immune system hyperactivity in skin tissues.
- ✅ High Concentration: The 2% active ingredient content ensures deep penetration and a pronounced anti-inflammatory effect.
- ✅ Safe Profile: Topical application significantly reduces the risk of side effects related to internal organs and blood.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 21.04.2026
Similar products
What Customers Say
No reviews yet
Your review can be the first!